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Adult neurogenesis persists in the subventricular
zone and the dentate gyrus and can be induced
upon central nervous system injury. However, the
final contribution of newborn neurons to neuronal
networks is limited. Here we show that in neural
stem cells, stimulation of the ‘‘death receptor’’ CD95
does not trigger apoptosis but unexpectedly leads
to increased stem cell survival and neuronal specifi-
cation. These effects are mediated via activation
of the Src/PI3K/AKT/mTOR signaling pathway, ulti-
mately leading to a global increase in protein transla-
tion. Induction of neurogenesis by CD95 was further
confirmed in the ischemic CA1 region, in the naive
dentate gyrus, and after forced expression of
CD95L in the adult subventricular zone. Lack of
hippocampal CD95 resulted in a reduction in neuro-
genesis and working memory deficits. Following
global ischemia, CD95-mediated brain repair rescued
behavioral impairment. Thus, we identify the CD95/
CD95L system as an instructive signal for ongoing
and injury-induced neurogenesis.
INTRODUCTION
In the adult central nervous system (CNS), ongoing neurogenesis
persists in two regions, the subventricular zone (SVZ) of the lateral
ventricles and the subgranular zone (SGZ) of the hippocampal
dentate gyrus (DG) (Lois and Alvarez-Buylla, 1993). In the DG
and SVZ, large numbers of neurons are generated from neural
stem cells (NSCs), but most die and never integrate into the
neuronal circuitry. The number and integration of newly born
neurons in the DG can be greatly enhanced by voluntary running,
although the exact underlying mechanism remains elusive (Zhao178 Cell Stem Cell 5, 178–190, August 7, 2009 ª2009 Elsevier Inc.et al., 2008). Also, under pathological conditions such as stroke,
proliferation of NSCs increases and newborn neurons migrate to
the site of damage (Lindvall et al., 2004). However, in this latter
scenario, most of the newly born neurons die, thus rendering
the replacement of mature injured neurons inefficient (0.2%)
(Emsley et al., 2005; Arvidsson et al., 2002; Parent et al., 2002).
Neurogenesis is enhanced by increased survival and neuronal
specification of stem cells or increased survival of newborn
neurons. Although survival seems to be such a critical aspect of
neurogenesis and NSC function, little is known about the mech-
anisms and molecules that make stem cells undergo death in
the naive or injured brain.
One of the molecules that induces apoptosis after brain injury
and in neurodegenerative diseases is CD95 (Fas/APO-1) and its
ligand CD95L (Demjen et al., 2004). Recently, CD95 has also
emerged as a molecule involved in nonapoptotic signaling
(Sancho-Martinez and Martin-Villalba, 2009). In the CNS, CD95L
promotes dendritic branching in immature neurons, outgrowth
of dorsal root ganglions in vitro, and migration of glioblastoma
cells (Desbarats et al., 2003; Kleber et al., 2008; Zuliani et al.,
2006).
Here we report that the CD95/CD95L system is an inducer of
neurogenesis in the adult brain. CD95 stimulation on NSCs
induces differentiation and survival of NSCs. This is mediated
by activation of the Src/PI3K/AKT/mTOR signaling pathway,
which results in a global increase in protein translation associated
with neuronal differentiation. In vivo, CD95-induced neurogene-
sis is involved in neuronal replacement of ischemic neurons as
well as ongoing neurogenesis and working memory formation.
RESULTS
CD95 Induces Neurogenesis by Activating
and Supporting Survival of NSCs In Vitro
The CD95 receptor has been well established as an inducer of
apoptosis (Krammer, 2000). To study its effect on cultured
NSCs, we treated neurosphere cultures with a recombinant
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CD95 Induces Neurogenesispretrimerized CD95L (CD95L-T4) (see Figure S1 available on-
line). As previously reported (Ricci-Vitiani et al., 2004), CD95 is
expressed on human and mouse NSCs (Figures S2A and S2B).
When CD95 was stimulated on NSCs, they did not undergo
apoptosis (Figures S2C and S2D). Instead, treatment of SVZ
NSC cultures with CD95L-T4 increased the number of cells posi-
tive for the neuronal marker b-III-tubulin (Figures 1A and 1B). To
control for specificity of the observed effect of CD95 on differen-
tiation, we treated NSCs derived from lpr mice (Adachi et al.,
1993), where CD95 was absent (Figure S2A). In these cells,
CD95L-T4 did not induce differentiation, confirming a specific
signaling of CD95L-T4 through CD95 (Figure 1C).
We further asked if treatment with CD95L-T4 could enhance
differentiation into a neuronal lineage when cells were induced
to differentiate by plating and culturing in differentiation medium
(Figure 1D). CD95L significantly increased the number of the
neuronal markers b-III-tubulin (Figures 1E and 1F), NeuN (Figures
1H and 1I), and calretinin (Figures 1J and 1K) as compared to
untreated cells, while the percentage of cells expressing the glial
marker GFAP was not changed (Figure 1G). Also in human NSCs,
CD95 stimulation resulted in an increased generation of neurons
(Figure S2E). The increase in the number of neurons could either
be due to an effect of CD95L on differentiation or on proliferation
of neuronally committed progenitors. CD95L-T4 treatment did
not enhance proliferation, suggesting that the increase in b-III-
tubulin-positive cells was rather due to induction of differentia-
tion (Figure S2F).
Neurosphere cultures mainly consist of neural progenitor cells,
while putative NSCs are rare (Singec et al., 2006). Therefore, to
study the response of actual stem cells to CD95L, we performed
a neurosphere assay that specifically addresses the response of
putative stem cells to an external factor (Ferron et al., 2007)
(Figure 1L). In wt NSCs that expressed CD95 (CD95 floxNesCre),
but not in CD95-negative NSCs (CD95 floxNesCre+), stimulation of
CD95 resulted in a significantly higher number of secondary
spheres (Figure 1M). The increased number of secondary neuro-
spheres can be the result of increased proliferation or survival of
stem cells. The former would imply that secondary spheres from
CD95L-T4-treated primary spheres have a higher ratio of NSCs
to progenitor cells than their control counterparts and, thus, a
resulting higher number of tertiary spheres. The latter implies
that the ratio of NSC to progenitor cells within each sphere
does not differ between the two groups and, therefore, neither
the number of arising tertiary spheres. The fact that CD95 stim-
ulation did not increase secondary neurosphere size (Figure 1O)
and no differences in tertiary sphere size (Figure 1P) or number
(Figure 1N) were found indicates that CD95L mainly acts on
survival and activation/differentiation of NSCs.
CD95 on NSCs Signals through PI3K Activation
How does CD95 increase survival and/or activation of NSCs?
Induction of apoptosis via CD95 occurs through the recruitment
of the adaptor protein FADD to the death domain (DD) of the
CD95. FADD recruitment to CD95 upon treatment with CD95L
could not be detected, indicating that FADD seems not to be
involved in the pathway inducing differentiation downstream of
CD95 (Figure 2A). By contrast, FADD recruitment to CD95 was
readily observed in lysates from an ischemic mouse brain
(Figure S3A). Also, we did not detect caspase-3 cleavage orcaspase activation in NSCs upon CD95 stimulation (Figures
S3B and S3C). Lack of FADD recruitment to CD95 upon
CD95L stimulation was also observed in glioblastoma cells
(Kleber et al., 2008). In these cells, CD95L stimulation induced
association of the p85 subunit of PI3K and of the Src family
kinase (SFK) member Yes to CD95, finally resulting in activation
of the PI3K pathway. Indeed, also in NSCs, PI3K activity, as
measured by ELISA-based detection of PI(3,4,5)P3, increased
after treatment of cells with CD95L-T4 (Figure 2B). Stimulation
of CD95 further resulted in phosphorylation of the PI3K down-
stream targets AKT and GSK3b (Figure 2C). In NSCs, immuno-
precipitation experiments revealed increased association of
CD95 with the regulatory p85 subunit of PI3K and the SFK
member pp60-src, but not of other SFKs upon CD95 stimulation
(Figure 2D and Figure S3B). We further examined the activation
state of pp60-src in CD95L-T4-treated and untreated NSCs.
Immunoprecipitates of tyrosine phosphorylated proteins were
further probed with an antibody that specifically recognizes
phosphorylated Y416 in the activation loop of src. pp60-src
was phosphorylated and thereby activated 5 min after stimula-
tion with CD95L-T4 (Figure 2E). Further supporting a role for
pp60-src in activation of PI3K siRNA, knockdown of pp60-src
inhibited CD95L-T4-mediated increase in p85 recruitment to
CD95 (Figure 2F). Also, knockdown of pp60-src or a dominant-
active form of GSK3b blocked CD95L-T4-mediated increase of
b-III-tubulin expression (Figures 2G and 2H). The PI3K inhibitor
LY294002 or the SFK inhibitor PP2 blocked CD95-induced
GSK3b phosphorylation (Figure 2I). These data indicate that in
NSCs, CD95L induces b-III-tubulin expression via the Src/PI3K
axis. But what makes NSCs undergo CD95-mediated survival/
differentiation and not apoptosis? In glioma cells, we previously
reported that knockdown of Yes enables FADD recruitment, and
therefore Yes seems to compete with FADD for binding to CD95
(Kleber et al., 2008). Yet knockdown of pp60-src in NSCs did not
facilitate recruitment of FADD to CD95 (Figure 2J). This finding
suggests the presence of other adaptor molecules and/or post-
translational modifications that could prevent FADD binding and
therefore apoptosis.
CD95 Stimulation Induces Changes in Gene Expression
and a Global Increase in Translation
To further analyze CD95-induced differentiation of NSCs, we
performed a translation-state array analysis (TSAA). Total mRNA
and polysome-bound mRNA from CD95L-T4-treated and
untreated NSCs were extracted and hybridized onto gene micro-
arrays. Despite the fact that 79% of CD95L-regulated polysome-
bound transcripts were also differentially regulated in the total
fraction (Figure 3A), the higher fold change and mode of regula-
tion of common genes allowed the identification of gene signa-
tures for neurogenesis, protein biosynthesis, and transcription
only in the polysomal fraction (Figure 3B). In both fractions, regu-
lated processes involved basal cellular processes participating
in cell differentiation as assessed by Gene Ontology Consortium
and pathway analysis (Figures 3A and 3B, Figure S4, and Tables
S3 and S4). Of the genes that were downregulated in CD95L-
treated NSCs, we validated Hes1, Hes5, and Jagged1, three
genes involved in Notch signaling using quantitative real-time
PCR (Figure 3C). We also validated two genes that were upregu-
lated upon CD95 stimulation in both the total and polysomalCell Stem Cell 5, 178–190, August 7, 2009 ª2009 Elsevier Inc. 179
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CD95 Induces NeurogenesisFigure 1. CD95 Stimulation Induces Neuronal Differentiation and Survival of NSCs
(A) Treatment scheme for (B) and (C).
(B and C) (B) FACS quantification of b-III-tubulin-positive NSCs from wt (4.22% ± 0.926 versus 30.17% ± 2.8, mean ± SD, n = 4) mice and (C) lpr mice.
(D) Treatment scheme for (E)–(K).
(E) Representative pictures of SVZ NSCs cultures differentiated for 4 days in the presence or absence of CD95L-T4.
(F and G) (F) Quantification of b-III-tubulin (4.31% ± 1.25 versus 10.24% ± 2.00, n = 10) and GFAP-expressing cells (G).180 Cell Stem Cell 5, 178–190, August 7, 2009 ª2009 Elsevier Inc.
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CD95 Induces Neurogenesisfractions known to be crucial for neuronal differentiation: Neuro-
genin1 (Ngn1), a major proneural transcription factor (Sun et al.,
2001), and brain-derived neurotrophic factor (BDNF), which has
been shown to mediate survival and differentiation of NSCs
(Sairanen et al., 2005) (Figure 3D).
A pathway downstream of PI3K is the mTOR signaling
pathway. A hallmark of mTOR signaling is an increase in transla-
tion and protein synthesis brought about by phosphorylation and
inactivation of its downstream target 4E (eIF4E) binding protein
(4EBP), an inhibitor of translation. In murine embryonic stem cells
(ESCs) (Sampath et al., 2008), differentiation into embryoid
bodies goes along with phosphorylation of 4EBP, thus abolish-
ing the block on translation initiation. Similar to differentiating
murine ESCs (Sampath et al., 2008), CD95L-T4 induced a global
increase in ribosome-bound mRNA (Figure 4A) and therefore
protein translation. CD95 stimulation also resulted in increased
phosphorylation of 4EBP (Figure 4B). To address the role of
mTOR in CD95-induced neurogenesis, its pharmacological
inhibitor Rapamycin was used. Treatment with Rapamycin
inhibits 4EBP phosphorylation, thereby increasing the interaction
between eIF4E and 4EBP and inhibiting cap-dependent transla-
tion (Gingras et al., 2001). The CD95-induced increase in NSCs
expressing b-III-tubulin was blocked by Rapamycin (Figure 4C).
At the mRNA level, CD95-mediated increase of Ngn1 and
decrease of Hes5 mRNA expression was similarly inihibited
by Rapamycin (Figures 4D and 4E). By contrast, retinoic acid
(RA)-induced decrease of Hes5 mRNA was unaffected by Rapa-
mycin treatment, whereas mRNA levels of Ngn1 were not influ-
enced by RA alone and subsequently neither by treatment with
RA and Rapamycin (Figures 4D and 4E). Taken together, TSAA
revealed that CD95-induced differentiation does not only result
in changes on gene expression known to be important for
neuronal differentiation, it also allows the identification of a global
differentiation signature and shows that neuronal differentiation
is accompanied by increased translation and protein synthesis
through the mTOR pathway. Thus, we propose a molecular
model for CD95-induced neurogenesis that involves activation
of the PI3K/AKT/mTOR and the PI3K/AKT/GSK3b signaling path-
ways (Figure 4F).
CD95L Overexpression Enhances Neurogenesis
in the Adult SVZ
Since CD95L could induce survival and differentiation of NSCs
in vitro, we asked if CD95L was also involved in neurogenesis
in vivo. We first analyzed expression of CD95 in the adult SVZ.
CD95 was detected in Nestin-positive, GFAP-positive, and
some DCX-positive cells present in the SVZ, but not DCX-positive
cells migrating into the rostral migratory stream (RMS) (Figures5A–5F and data not shown). Accordingly, fluorescence-activated
cell sorting (FACS) of CD95-positive cells from the SVZ revealed
that 1.2% of all SVZ cells express CD95. Further, only CD95-
expressing cells were able to form neurospheres when plated
at a low density (Figures S6G and S6H). The role of CD95L in
the SVZ was analyzed by injecting lentiviral vectors carrying
CD95L-IRES-GFP or GFP only in the lateral ventricles (Figure 5G).
Lentiviral infection was mainly observed in tissue along the
ventricle and in the SVZ, and infection rate was comparable in
the two groups (data not shown). Mice that were injected with
the GFP-only virus showed normal neurogenesis in viral infected
areas (Figures 5H–5J). In contrast, in animals injected with
CD95L-IRES-GFP, we observed a marked increase in cells
expressing Doublecortin (DCX), a marker for immature neurons,
in CD95L and GFP-infected areas (Figures 5K–5M). DCX-
expressing cells in CD95L-IRES-GFP-infected areas further
exhibited a mature morphology with more elaborate processes
protruding into the adjacent parenchyma. Importantly, stereolog-
ical quantification revealed a marked increase in DCX-positive
regions upon forced expression of CD95L in the SVZ, a phenom-
enon often associated with the reported reactive neurogenesis
found upon neurodegenerative diseases or ischemic injury to
the CNS (Yang and Levison, 2006) (Figures 5N–5P).
CD95 Is Required for Neurogenesis in a Model of Global
Ischemia
We further examined the role of CD95 in the reactive neurogen-
esis induced upon ischemic injury. CD95L is highly upregulated
following injury to the CNS (Martin-Villalba et al., 1999). In the
mouse model of global ischemia, which is characterized by
apoptosis of neurons in the CA1 region of the hippocampus
(Martin et al., 2000), CD95L expression was induced as detected
by real-time PCR and FACS analysis in the hippocampus 3 days
after global ischemia (Figure 6A). Accordingly, when we analyzed
tissue from a human patient who suffered from global ischemia
resulting from heart failure, we detected CD95L expression in
pyramidal neurons in the CA1 region (Figure 6B). In the DG of
this patient, CD95 was expressed in few cells in the subgranular
layer (Figure 6C). In this region, we also observed Nestin-positive
cells that are putative NSCs (Figure 6C). Analysis of the DG in
mouse brain slices showed a colocalization of CD95 with
GFAP-positive cells (Figure S6D). After global ischemia, the
number of existing NSCs seems to be the limiting factor for
regeneration, since expansion of NSCs by EGF infusion allows
effective regeneration of the injured CA1 region by recruitment
of NSCs (Nakatomi et al., 2002). To provide a sufficient number
of NSCs, while avoiding confounding effects related to EGF infu-
sion, we transplanted GFP-labeled SVZ NSCs into the brain of(H–J) Representative pictures of SVZ NSCs cultures differentiated for 7 days in the presence or absence of CD95L-T4. Expression of b-III-tubulin and NeuN (H)
and calretinin (J) are depicted. (I) Quantification of b-III-tubulin (5.2883% ± 1.4221 versus 17.3101% ± 1.9818)- and b-III-tubulin/NeuN (3.0661% ± 0.3194 versus
7.1052% ± 0.3979)-expressing cells.
(K) Quantification of calretinin-expressing cells (4.2428% ± 0.1241 versus 11.5439% ± 1.2720).
(L) Treatment scheme for neurosphere assay.
(M) Numbers of secondary spheres from CD95floxNesCre- and CD95floxNesCre+-derived NSCs without or with CD95L-T4 treatment (26.83 ± 1.66 versus
38.17 ± 1.54, n = 20).
(N) Numbers of tertiary spheres from CD95floxNesCre- and CD95floxNesCre+-derived NSCs without or with CD95L-T4 treatment.
(O) Sizes of secondary and tertiary spheres from CD95floxNesCre-derived NSCs.
(P) Sizes of tertiary spheres from CD95floxNesCre-derived NSCs. Data are depicted as mean ± SEM from at least four biological replicates (Student’s t test,
*p < 0.05; **p < 0.01).Cell Stem Cell 5, 178–190, August 7, 2009 ª2009 Elsevier Inc. 181
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CD95 Induces NeurogenesisFigure 2. CD95 Stimulation Activates PI3K Signaling through Activation of pp60-src
(A) Lysates from stimulated or nonstimulated SVZ NSCs were analyzed for FADD recruitment. CD95 was immunoprecipitated, and immunoprecipitates were
blotted for FADD and CD95. *, specific band.
(B) Changes in PI3K activity were measured by using a photometric PI3K activation kit.
(C) NSCs were stimulated with different concentrations of CD95L-T4, and lysates were blotted for phospho-AKT/PKB (Ser473) or its downstream target phospho-
GSK3b (Ser9).
(D) NSCs were stimulated with CD95L-T4. CD95 was immunoprecipitated, and the membranes were probed with anti-p85, anti-pp60-src, and anti-CD95 anti-
bodies. *, specific band.
(E) Anti-phosphotyrosine antibody was used for immunoprecipitation, and immunoprecipitates from CD95L-T4-treated and untreated cells were blotted with an
antibody detecting phosphorylated active Src (Y416).
(F) pp60-src knockdown was performed using siRNA and analyzed by western blot (left panel). Immunoprecipitation of CD95 was performed after pp60-src
knockdown (right panel).
(G) CD95L-T4-induced differentiation of lipofectamine-treated (4.8900% ± 1.6100 versus 17.1500% ± 0.6500) and scrambled siRNA-treated NSCs (4.6900% ±
0.1600 versus 18.0700% ± 4.0900) was significantly blocked by pp60-Src knockdown (4.3150% ± 0.4350 versus 5.2300% ± 0.7900) as measured by b-III-tubulin
expression.182 Cell Stem Cell 5, 178–190, August 7, 2009 ª2009 Elsevier Inc.
Cell Stem Cell
CD95 Induces Neurogenesisinjured mice 48 hr after ischemia. Three weeks after injection, we
found GFP+ cells in the injured CA1 region. Some of these cells
expressed phosphorylated GSK3b, indicating that phosphoryla-
tion of GSK3b might play also a role in neuronal differentiation
in vivo (Figure 6D). To test if CD95L expressed after ischemia
could be involved in neuronal differentiation of transplanted
progenitors, we compared SVZ NSCs derived from either wt or
lpr mice (Figure 6E). Notably, 10 weeks after injection, we found
GFP+ cells in the CA1 region in mice that received wild-type cells.
These cells exhibited a neuronal morphology, and some of these
cells expressed the mature neuronal marker NeuN (Figure 6F). In
mice that received lpr cells, GFP+ cells in the CA1 region were
scarce, and only a few cells coexpressed GFP and NeuN
(Figures 6F and 6G). The fact that lpr NSCs were found in the
Figure 3. Translation-State Array Analysis
of CD95L-Treated and Untreated NSCs
(A) Schematic diagram showing CD95L-depen-
dent gene expression changes at the total and
polysomal mRNA levels. Note the differential regu-
lation in the different fractions of common genes
(red and green arrows).
(B) Clusters of polysome-bound transcripts
involved in transcription, neurogenesis, and
protein biosynthesis identified by hierarchical
clustering. Color codes are green for downregu-
lated genes, red for upregulated genes, and black
for no changes.
(C and D) Validation of microarray data by qRT-
PCR of selected CD95L-regulated transcripts.
Data are expressed as mean ± SEM of four
independent biological samples (Student’s t test,
*p < 0.05; **p < 0.01).
ischemic region and that in vitro, lpr cells
could be readily differentiated into
neurons when induced to differentiate
by plating and cultivating in differentiation
medium (data not shown) suggests that
they have no intrinsic deficits but that
the CD95L/CD95 interaction is required
for survival and differentiation of NSCs
after global ischemia in the CA1 region.
To test whether transplanted NSCs
were functional, we asked if they could
improve behavioral deficits associated
with hippocampal lesions. The T-maze
test is a measure for working memory
and crucially dependent on hippocampal
function (Deacon and Rawlins, 2006;
Whishaw and Tomie, 1996). In this test,
a mouse is placed in the start arm and allowed to explore one
arm of the maze, while the other arm is blocked (Figure 6H, upper
panel). In the next run, the block is removed and the mouse is
placed again in the start arm. It can now choose between the
previously explored or the novel arm. Rodents prefer the novel
arm above chance, a behavior known as spontaneous alterna-
tion (Figure 6H, lower panel). Ischemic mice showed significantly
reduced success rates in working memory in the T-maze test
compared to naive controls (Figure 6I). This defect in sponta-
neous alternation behavior was rescued in mice injected with
wt NSCs, indicating that wt NSCs are able to integrate into the
brain circuitry and improve ischemia-induced deficits. In
contrast, mice that received lpr NSCs exhibited significantly
decreased spontaneous alternation rates comparable to(H) SVZ NSCs were infected with a lentiviral construct carrying either eGFP alone or a constitutively active mutant of GSK3b (S9/A) and eGFP. Forty-eight hours
after stimulation with CD95L-T4, FACS analysis for b-III-tubulin expression of eGFP-positive cells was performed. Cells expressing GFP only showed an increase
in b-III-tubulin-positive cells (4.6500 ± 0.2500 versus 19.2750 ± 3.6550), while this was blocked in cells infected with GFP and GSK3b (S9/A) (4.5000 ± 0.1000
versus 4.7100 ± 0.1900).
(I) Treatment with the PI3K inhibitor LY 294002 or the Src inhibitor PP2 reduced CD95L-T4-induced phosphorylation of GSK3b in NSCs.
(J) CD95 was immunoprecipitated from pp60-src siRNA, and scrambled siRNA-treated cells under stimulated and nonstimulated conditions and immunoprecip-
itates were blotted for FADD. Data in (B), (G), and (H) are expressed as mean ± SEM from each of three independent biological replicates (Student’s t test,
*p < 0.05; **p < 0.01).Cell Stem Cell 5, 178–190, August 7, 2009 ª2009 Elsevier Inc. 183
Cell Stem Cell
CD95 Induces NeurogenesisFigure 4. CD95L Induces a Global Increase in Translation
(A) Comparison of polysome profiles of CD95L-T4-treated and untreated SVZ NSCs 48 hr after stimulation and quantification of the area under the curve for
monosome and polysome regions.
(B) Western blot depicting phosphorylation of 4EBP upon CD95L-T4 treatment.
(C) Rapamycin treatment abolishes the CD95L-induced increase in b-III-tubulin-positive cells (32.1667% ± 0.7839 versus 14.4667 ± 1.3691).
(D and E) qRT-PCR of selected CD95L-regulated transcripts with or without Rapamycin treatment.
(F) Schematic drawing of proposed signaling events in CD95 signaling in NSCs. Data in (A) and (C) are expressed as mean ± SEM of four independent
biological samples; data in (D) and (E) are triplicate samples from three independent biological replicates and are expressed as mean ± SEM (Student’s
t test, *p < 0.05; **p < 0.01).ischemic animals with injection of PBS (Figure 6I). lpr NSCs did
not integrate into the damaged CA1 and thus were not able to
ameliorate behavioral deficits. There were no significant differ-
ences between the groups in the motor activity in the open field
test, indicating that the effects seen in the spontaneous alterna-
tion were not due to changed motor activity or exploratory
behavior in the different groups of mice (data not shown).
CD95 Deficiency Results in Reduced Working Memory
Formation and Neurogenesis
Recent research suggests that ongoing neurogenesis is an
important process for normal hippocampal function. Mice in
which neurogenesis has been ablated show deficits in hippo-
campal-dependent learning tasks such as the Morris water
maze and fear conditioning (Drapeau et al., 2003; Dupret et al.,
2008; Zhang et al., 2008). Also, lpr mice have been shown to
exhibit deficits in learning and memory (Sakic et al., 1997) that
might be linked to defects in neurogenesis. In lpr mice, working
memory was analyzed by testing their spontaneous alternation
rates in the T-maze (Figure 6H). lpr mice exhibited significantly
lower success rates in the T-maze compared to wt controls
(Figure 7B, left). As these mice have a deregulated immune
system (Andrews et al., 1978; Sakic et al., 1997), we generated
animals lacking CD95 in neural cells while leaving the immune
system unaffected (CD95 floxNesCre+ mice) to exclude defects184 Cell Stem Cell 5, 178–190, August 7, 2009 ª2009 Elsevier Inc.related to autoimmune destruction of synapses (Figure S5B).
CD95 floxNesCre+ mice also showed significantly lower success
rates in the T-maze than did control littermates (Figure 7C,
left). To further rule out any influence of the previously reported
role of CD95 in neuronal development (Zuliani et al., 2006), we
studied working memory in CD95 floxNesCreERT2 mice in which
tamoxifen induced Cre recombination in adult neural stem and
progenitor cells. These mice still performed significantly worse
in the T-maze compared to their control littermates (Figure 7D).
Several studies have shown that wheel running enhances
performance of rodents in hippocampal-dependent learning
tasks by acting on hippocampal neurogenesis (Van der Borght
et al., 2007; van Praag et al., 2005). To corroborate that the
observed defect in working memory is due to reduced neuro-
genesis, we gave lpr and CD95 floxNesCre+ mice and their
respective controls access to a running wheel in their home
cage (Figure 7A). Voluntary running rescued the defect exhibited
by nonrunner lpr and CD95 floxNesCre+ mice in T-maze alterna-
tion 3 weeks after initiation of running (Figures 7B and 7C).
Importantly, 3 months after termination of running, this rescue
effect disappeared (Figure 7B, right). The fact that mice with
CD95 deletion in adult progenitor cells exhibit deficits in working
memory that can be rescued by running, but only momentarily,
indicates that working memory is dependent on newly gener-
ated neurons and their known higher plasticity as far as they
Cell Stem Cell
CD95 Induces Neurogenesisare young, and that these neurons can be generated by activa-
tion of CD95.
To further confirm that working memory deficits in CD95-defi-
cient mice were indeed due to reduced neurogenesis, the
number of newborn neurons was assessed by examining the
number of newly generated immature neurons (BrdU/DCX-cells).
One day after BrdU administration, lpr (Figures 7E and 7G), CD95
floxNesCre+ (Figure 7I and Figures S5C and S5D), and CD95
floxNesCreERT2+ (Figure 7J) mice showed a significant reduction
Figure 5. CD95L Expression Induces Neu-
rogenesis In Vivo
(A–E) Confocal images of CD95 expression in the
SVZ in cells coexpressing Nestin (C), Doublecortin
(DCX) (D), and GFAP (E).
(F) Scheme depicting CD95 expression pattern in
NSCs.
(G) Experimental setup for (H)–(O).
(H–J) Representative images of coronal sections
of animals injected with a lentivirus expressing
GFP.
(K–M) Representative images of coronal sections
of animals injected with CD95L- and GFP-
expressing LV.
(N) Representative images of sagittal sections of
animals injected with a lentivirus expressing GFP.
(O) Representative images of coronal sections of
animals injected with a lentivirus expressing
CD95L and GFP.
(P) Stereological quantification of DCX-positive
regions in animals injected with CD95L-GFP (n =
4) and GFP (n = 2). Scale bar, 50 mm. Data are
expressed as mean ± SEM.
in BrdU/DCX-positive cells in the DG
compared to respective controls. Volun-
tary running enhanced the number of
newly generated immature neurons and
subsequently mature ones in both lpr
and control animals and even compen-
sated for the deficit exhibited by nonrun-
ner lpr animals (Figures 7F–7H). Control
animals did not show an improvement in
working memory performance after run-
ning, although they exhibited increased
neurogenesis, possiblybecause aplateau
level was reached in the T-maze test.
Furthermore, deficiency of CD95 dimin-
ishes the number of newborn neurons
while leaving the number of BrdU-only
cells unaffected (Figure S6A). The de-
creased number of DCX-positive cells
was due to decreased generation and
not increased apoptosis, as demon-
strated by equivalent numbers of cas-
pase-3-positive cells inwt and lpr animals
(Figure S6C). Importantly, survival of new
neurons was not affected by CD95, as
shown by the same percentage of
surviving mature neurons (BrdU/NeuN
cells) in wt and lpr animals (Figure S6B).
To analyze if behavioral defects could be due to a decrease in
branching of immature neurons, we compared the morphology
of DCX-positive neurons that also expressed calretinin in
CD95floxNesCreERT2 and CD95floxNesCreERT2+ mice (Figure S7).
Although the overall number of DCX/Calretinin-positive cells
was lower in mice lacking CD95 on NSCs, the length and number
of dendrites as well as the number of branching points of imma-
ture neurons were comparable, indicating that the behavioral
deficits in mice lacking CD95 were not due to a decrease inCell Stem Cell 5, 178–190, August 7, 2009 ª2009 Elsevier Inc. 185
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CD95 Induces NeurogenesisFigure 6. CD95 Is Involved in Injury-Induced Neurogenesis
(A) Three days after global ischemia, CD95L mRNA is upregulated in the hippo-
campus (1 versus 1.7075 ± 0.1161, n = 4). FACS staining of hippocampal
tissue reveals an increase in CD95L-positive cells (1 versus 3.8075 ± 0.4008,
n = 4).
(B) Tissue samples from a patient with global ischemia were immunohisto-
chemically analyzed. Cells positive for CD95L (arrows) could be seen in the
ischemic CA1 region of the hippocampus.
(C) In the DG of the patient, cells are positive for CD95 (left) and Nestin (right)
(arrows).186 Cell Stem Cell 5, 178–190, August 7, 2009 ª2009 Elsevier Inc.branching of newly born neurons (Figures S7A and S7B). In the
naive adult hippocampus, CD95 and CD95L were expressed in
cells of the subgranular layer of the DG that exhibited a radial
glia-like morphology and expressed GFAP—putative NSCs
(Figures S6D–S6F). Accordingly, CD95 sorting of hippocampal
cells revealed that only CD95-positive but not CD95-negative
cells form neurospheres when seeded at a low density, suggest-
ing that they are putative NSCs (Figure S6H).
DISCUSSION
Apoptosis, Neurogenesis, and the Death Receptor CD95
Here we report that a ‘‘death receptor’’ increases survival and
neuronal differentiation of NSCs. That a factor in charge of driving
damaged cells into apoptosis is also involved in their replacement
by newborn cells is not surprising, given that apoptosis and neu-
rogenesis go hand in hand. Already Magavi and colleagues
showed that neurogenesis can be readily induced in the non-
neurogenic cortex if selective apoptosis of cortical neurons is
triggered (Magavi et al., 2000). Apoptosis and neurogenesis are
also closely related in ongoing hippocampal neurogenesis.
Many progenitor cells are born in the hippocampus every day,
but only a small fraction survives and integrates in the neuronal
circuitry (Aimone et al., 2006; Zhao et al., 2008). Furthermore,
learning promotes apoptosis of superfluous DCX-positive cells,
and blocking of apoptosis impairs learning (Dupret et al., 2007).
Likewise, upon brain injury or neurodegenerative disease, neural
progenitors in the SVZ proliferate, resulting in an expansion of the
SVZ. In our study, we observed a similar broadening of the SVZ
when we injected CD95L-expressing lentivirus in the lateral
ventricles. Finally, following global ischemia, selective apoptosis
of ischemic CA1 neurons allows efficient neuronal replacement
by newly born neurons. In summary, CD95-induced neurogene-
sis goes along with apoptosis.
CD95-Induced NSC Differentiation Is Characterized by
Activation of PI3K and an Increase in Protein Synthesis
and Translation
Our data show that in NSCs CD95 does not induce apoptosis
but results in activation of the Src/PI3K/GSK3b-mTOR pathway.
(D) Three weeks after injection, GFP+ cells are found in the CA1 region of the
hippocampus and colocalized with phosphorylated GSK3b (arrows). Scale
bar, 15 mm.
(E) Treatment scheme for (F) and (G).
(F) Confocal maximum projections images (z = 15 mm) of the CA1 region of
mice transplanted with wt or lpr NSCs (arrows; green, GFP+/NeuN; yellow,
GFP+/NeuN+).
(G) GFP+ cells in the CA1 region are quantified (lower panel). Brain slices (50mm)
were analyzed in a one-in-six series of sections (250 mm apart). NeuN immuno-
reactivity was used to measure the volume of the CA1 region. Mice injected with
wt NSCs exhibited a higher number of GFP-positive (15133.4682 ± 1396.3
versus 6956.1219 ± 657.1975) and NeuN and GFP double-positive cells
(10907.4183 ± 2060.8436 versus 3096.3030 ± 670.9253) in the CA1 region.
(H) Experimental setup of spontaneous alternation.
(I) Global ischemia reduces the success rate in spontaneous alternation
(66.44% ± 4.58 versus 55.76% ± 3.9, n = 13). Transplantation of wt (64.42% ±
2.77%, n = 13) but not lpr NSCs (50.96% ± 3.3, n = 13) rescues the behavioral
deficit 5 weeks after injection. Scale bar for all experiments except in (D), 50mm.
Data are expressed as mean ± SEM. Statistics are as follows: Student’s t test
for (A) and (G); for (I), Kruskal-Wallis analysis (*p < 0.05).
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CD95 Induces NeurogenesisFigure 7. CD95 on Neural Progenitor Cells Is Involved in Working Memory and Neurogenesis
(A) Timeline of the experiments performed.
(B) lpr mice show significantly reduced success rates in the T-maze performance compared to wt controls (51.78% ± 4.13 versus 67.19% ± 3.864). Running
rescues deficits in the working memory performance of lpr mice (76.79% ± 4.13). Three months after the end of the running period, lpr mice show again signif-
icantly reduced success rates in the T-maze (73.2143% ± 6.9160% versus 45.8333% ± 6.1802).
(C) CD95 floxNesCre+ (f/f Cre+) mice had a reduced success rate in spontaneous alternation (59.03% ± 4.31 versus 79.46% ± 4.25) compared to control littermates
(f/f Cre and f/+ Cre+). Success rates of Cre+ mice reached the level of control mice 1 week after wheel running (76.39% ± 6.05).
(D) CD95 floxNesCreERT2+ mice (Cre+) performed worse in the T-maze than did their control littermates (f/f Cre and f/+ Cre+) (66.67% ± 3.33 versus 78.33% ±
3.63).
(E and F) Representative images of DG neurogenesis of lpr and wt mice; nonrunners (E) and runners (F).
(G–I) Stereological quantification of neurogenesis (G) lpr mice showed significantly reduced numbers of newborn immature neurons (BrdU/DCX) at 24 hr after
injection of BrdU (356.1 ± 26.69 versus 862.02 ± 55.33, n = 5) . After running, lpr and wt mice had similar numbers of BrdU/DCX cells. (H) The 4 week survival
of generated neurons (BrdU/NeuN-cells) was significantly reduced in lpr mice compared to wt mice (129.69 ± 39.34 versus 278.16 ± 32.49, n = 6) and enhanced
by voluntary running. (I) CD95floxNesCre+ mice show reduced numbers of DCX/BrdU-cells 24 hr after injection of BrdU compared to control littermates (389.34 ±
34.57 versus 929.89 ± 8.58, n = 5).
(J) CD95floxNesCreERT2+ mice show reduced numbers of DCX/BrdU-cells 24 hr after injection of BrdU compared to control littermates (577.9256 ± 59.2357 versus
197.8116 ± 41.1549, n = 5). f, flox; DG, dentate gyrus. Scale bars, 50 mm. Data are expressed as mean ± SEM. Statistics are as follows: multiway ANOVA followed
by Holm-Sidak for (B) and (C); Student’s t test for (G)–(J) (*p < 0.05; **p < 0.001).Cell Stem Cell 5, 178–190, August 7, 2009 ª2009 Elsevier Inc. 187
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CD95 Induces NeurogenesisIn the past, several reports have pointed out an important role for
PI3K in CD95-induced signaling (Eischen et al., 1994; Schlott-
mann et al., 1996). These reports, however, suggested that
CD95-induced tyrosine phosphorylation is a prerequisite for
CD95-mediated apoptosis. Likewise, the phosphatases SHP-
1, SHP-2, and SHIP were found to associate with CD95 to coun-
teract survival-factor-initiated pathways (Daigle et al., 2002). In
glioblastoma cells, however, we found that the SFK kinase
Yes, and not pp60-src, as in NSCs, is recruited to CD95 together
with the PI3K subunit p85, resulting in activation of AKT to signal
invasion and not apoptosis (Kleber et al., 2008). Thus, in glioblas-
toma cells and NSCs, different mediators lead to PI3K activation
to increase tumorigenesis or neurogenesis, respectively. This
finding might support one aspect of the cancer stem cell theory:
that at least some cells found in glioblastoma share some
signaling pathways with NSCs.
A downstream effector of PI3K is mTor and its target 4EBP.
4EBP competes with eIF4G for binding to eIF4E, thus preventing
translation. Phosphorylation of 4EBP is thought to inactivate it
and enhance initiation of translation and ribosome biogenesis.
In ESCs, it has recently been shown (Sampath et al., 2008) that
differentiation is characterized by a global increase in mRNA
transcript abundance, polysome content, protein synthesis,
and protein content controlled by several translational regulators
including mTOR and its target 4EBP. This ‘‘anabolic switch’’ is
also found in CD95L-induced differentiation of NSCs. Further,
analysis of polysome-bound transcripts revealed changes on
transcripts involved in cell differentiation, development, and
neurogenesis. Taken together, TSAA shows that CD95L evokes
changes on translation similar to ESC differentiation, and it also
suggests that regulation of ESC and NSC differentiation have
much in common.
CD95 and Running and Working Memory
We found that loss of CD95 expression on NSCs resulted in
decreased working memory performance and that mice lacking
CD95 exhibited reduced neurogenesis. The link between normal
hippocampal function and neurogenesis has been recently
established by studies in mice in which neurogenesis has
been ablated: these animals exhibit difficulties in hippo-
campal-dependent learning tasks such as the Morris water
maze and fear conditioning (Drapeau et al., 2003; Dupret
et al., 2007; Zhang et al., 2008). In this manuscript, we focus
on elucidating the role of CD95-induced hippocampal neuro-
genesis in hippocampal-dependent spatial/contextual working
memory. This is only reliably shown by testing animals on the
T-Maze paradigm. Previous studies have shown that acquisition
of spatial memory (water maze) and contextual fear conditioning
do not require stem cell activity (Shors, 2008). With regard to
spatial memory, it has been shown that animals can learn to
navigate space and emit the appropriate operant response
with very few if any newly generated neurons (Shors, 2008).
Likewise, animals can readily learn to fear a context despite
a scarce number of new neurons (Shors et al., 2002). Also,
genetic deletion of TLX in adult NSCs resulted in a significant
reduction of stem cells and suppression of neurogenesis that
did not affect contextual fear conditioning (Zhang et al., 2008).
In addition, repetitive training in spatial learning tasks could188 Cell Stem Cell 5, 178–190, August 7, 2009 ª2009 Elsevier Inc.prevent death of newly generated neurons and therefore
confound the studies that aim to distinguish the role of neuro-
genesis versus neural survival for behavioral function (Gould
et al., 1999; Sisti et al., 2007). Notably, in our work the rescue
of spontaneous T-maze alternation by voluntary running
provides evidence that ongoing neurogenesis specifically tunes
working memory. It is believed that less-specific firing of
newborn neurons, possibly due to presence of action-potential
boosting calcium spikes or GABA-mediated membrane depo-
larization, may help to encode information about unrelated
events, which occur close in time, into overlapping subsets of
CA3 (Aimone et al., 2006; Lledo et al., 2006). Our data show
that the number of these young neurons can be modulated after
voluntary physical experience. Interestingly, although the
number of neurons was increased only 1 day after completion of
voluntary running, this was not sufficient to rescue the working
memory deficit at that time. Moreover, running-elicited rescue
of working memory deficits disappeared at later time points.
This suggests that integration of these neurons into functional
circuits during a critical period mediates their role in working
memory formation.
We have previously demonstrated that stimulation of CD95 on
hippocampal and cortical developing neurons increases the
formation of branches (Zuliani et al., 2006). However, in the hippo-
campal DG, CD95 is expressed in GFAP-positive cells with radial
glial morphology, but not in newly born neurons. Besides, the
number of branches of DCX/calretinin-positive neurons was
comparable in wt and mutant mice. These data indicate that
the effect of CD95 in hippocampal-dependent working memory
is not related to CD95-induced branching. A possible alternative
explanation of the working memory deficits exhibited by mice
with deletion of CD95 in NSC might be that the CD95L-exposed
NSC supports the ‘‘well-being’’ of the newborn neurons by
providing a better extracellular niche. This could occur via the
secretion of survival-promoting factors, e.g., by secretion of
BNDF, which we found highly upregulated in NSCs upon CD95L
stimulation.
CD95 for Brain Repair
We have demonstrated that following global ischemia the CD95/
CD95L interaction supports neurogenesis. CD95L can kill
damaged neurons (Martin-Villalba et al., 1999), promote their
replacement by neural progenitor cells, and even support further
maturation of these newly generated neurons (Zuliani et al.,
2006). Following global ischemia, however, the number of newly
generated endogenous NSCs seems to be the limiting factor, as
EGF and bFGF-induced expansion of NSCs allowed for partial
recovery of ischemia-induced spatial learning deficits (Nakatomi
et al., 2002). If CD95L induces neurogenesis and is upregulated
in the diseased brain, why is neurogenesis after injury in most
cases not more pronounced? At the time at which CD95L has
its highest expression—the acute injury phase—apoptosis is in
most cases associated with massive induction of necrosis,
inflammation, and production of reactive oxygen species
(ROS). Unravelling the factors blocking CD95-mediated neuro-
genesis in the context of ischemia and neurodegeneration will
enable the use of CD95 to harness endogenously generated
NSCs to repair the diseased CNS.
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Animals
Animals used are described in Table S1. C57BL/6J mice were bought from
Charles River Laboratories. lpr mice (Adachi et al., 1993) were backcrossed
more than ten generations to C57BL/6J. CD95 floxed mice were bred with Nes-
tin-Cre or Nestin-CreERT2 mice. Eight-week old Nestin-CreERT2 mice and
respective controls (heterozygous and Cre) were i.p. injected twice a day
for 5 days with tamoxifen (2 mg/day). All animal experiments were performed
in accordance with the institutional guidelines of the German Cancer Research
Center and were approved by the Regierungspra¨sidium Karlsruhe, Germany.
Behavioral Tests
Behavioral tests were performed as described before (Deacon and Rawlins,
2006). For details, see the Supplemental Data.
In Vivo Neurogenesis
Age-matched CD95 floxNesCre+ and CD95 floxNesCre mice or wt and lpr mice
were injected with 300 mg/kg BrdU and perfused 24 hr after to analyze BrdU/
DCX-positive cells (n = 5), or alternatively, mice were injected on three consec-
utive days with 300 mg/kg BrdU and perfused 4 weeks after to analyze BrdU/
NeuN-positive cells (n = 6). To analyze activity-dependent neurogenesis in lpr
andwtmice, mice were injected for 12 consecutive days with BrdU (50 mg/kg).
During this time, animals had access to a running wheel. Animals were
perfused 1 day after to analyze BrdU/DCX, or alternatively, mice had another
4 weeks’ access to a running wheel and were perfused afterwards to analyze
BrdU/NeuN-positive cells (n = 5). For each animal, confocal stacks (30 mm
each) of six vibratome coronal brain slices (50 mm thick, 250 mm apart) were
acquired, and cells were counted. Cell numbers were normalized to the area
of the DG.
Global Ischemia and Neural Stem Cell Transplantation
Briefly, 12-week-old female C57BL6 mice were anesthetized, and common
carotoid arteries were exposed. Both carotoid arteries were occluded using
microclamps (Fine Science Tools). After 10 min, clamps were removed, and
the wound was closed. Forty-eight hours after global ischemia induction,
mice were anesthetized. Lentiviral infected NSCs were trypsinized, washed
in PBS, and resuspended at a concentration of 250,000 cells per ml medium.
Of the cell suspension, 2 ml was injected into the striatum using a Flexi-fill
syringe and a Micro4 syringe pump controller (World Precision Instruments)
at a rate of 200 nl/min. For histology, FACS analysis, or real-time PCR,
3 mice per group were used; for behavioral tests, 13 mice per group were used.
Translation-State and Microarray Analysis
Polysomal-bound and total RNA were isolated as described (Diehn et al., 2000)
and hybridized to Affymetrix GeneChip MOE430A2. For detailed experimental
procedures, see the Supplemental Data. Array data are publicly available at
GEO GSE15623.
Statistical Analysis
All results, unless otherwise stated, were analyzed by using Student’s t test.
Data in Figures 6I, 7B, and 7C were tested for statistical significance using
multiway ANOVA, and post hoc pairwise comparisons were performed using
Holm-Sidak test after correcting the p value (<0.05) for repeated comparisons
using Bonferroni correction method. All data are presented as mean ± stan-
dard error (SEM), unless otherwise stated.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, seven
figures, four tables, and Supplemental References and can be found with
the article online at http://www.cell.com/cell-stem-cell/supplemental/S1934-
5909(09)00213-6.
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